| Literature DB >> 32424418 |
Matthijs P S van Wijmen1, Bart P M Schweitzer1, H R Pasman1, Bregje D Onwuteaka-Philipsen1.
Abstract
OBJECTIVE: We compared the performance of two tools to help general practitioners (GPs) identify patients in need of palliative care: the Surprise Question (SQ) and the Supportive and Palliative Care Indicators Tool (SPICT).Entities:
Keywords: Cohort studies; computer-assisted; decision making; general practice; medical informatics; palliative care; sensitivity and specificity
Year: 2020 PMID: 32424418 PMCID: PMC7571774 DOI: 10.1093/fampra/cmaa049
Source DB: PubMed Journal: Fam Pract ISSN: 0263-2136 Impact factor: 2.267
Figure 1.Flowchart of the design and population of the study.
Descriptive data from the selections by the two tools from the two general practices at the start of the data collection in 2016
| SQ ( | SPICT | ||
|---|---|---|---|
| Step 1: preselection by the GPIS ( | Step 2: final selection by the GP ( | ||
| Sex | |||
| Male | 19 (28%; 19–40%) | 206 (41%; 37–45%) | 33 (33%; 24–42%) |
| Female | 48 (72%; 60–81%) | 295 (59%; 55–63%) | 68 (67%; 58–76%) |
| Age (years) | |||
| <60 | 0 (0%; 0–4%) | 105 (21%; 18–25%) | 0 (0%; 0–2%) |
| 60–69 | 4 (6%; 2–14%) | 133 (27%; 23–31%) | 10 (10%; 5–17%) |
| 70–79 | 10 (15%; 8–25%) | 117 (23%; 20–27%) | 21 (21%; 14–29%) |
| >80 | 53 (79%; 68–87%) | 146 (29%; 25–33%) | 70 (69%; 60–78%) |
| Disease | |||
| Cancer | 29 (43%; 32–55%) | 260 (52%; 48–56%) | 42 (42%; 32–51%) |
| Dementia | 20 (30%; 20–41%) | 39 (8%; 6–10%) | 29 (29%; 21–38%) |
| Heart failure | 16 (24%; 15–35%) | 35 (7%; 5–9%) | 23 (23%; 15–32%) |
| CVA | 10 (15%; 8–25%) | 50 (10%; 8–13%) | 17 (17%; 11–25%) |
| COPD | 10 (15%; 8–25%) | 43 (9%; 6–11%) | 13 (13%; 7–20%) |
| Renal failure | 21 (31%; 21–43%) | 125 (25%; 21–29%) | 34 (34%; 25–43%) |
| Liver disease | 0 (0%; 0–4%) | 7 (1%; 1–3%) | 0 (0%; 0–2%) |
| Neurological disease | 5 (7%; 3–16%) | 13 (3%; 1–4%) | 6 (6%; 3–12%) |
| Overlap selections | |||
| Also selected by: | |||
| SQ | 67 (100%) | 61 (12%) | 58 (57%) |
| SPICT—selection from GPIS | 61 (91%) | 501 (100%) | 101 (100%) |
| SPICT—selection by GP | 58 (87%) | 101 (20%) | 101 (100%) |
Absolute numbers (percentage; 95% confidence interval).
Case reports of the deceased in the two practices in the period of 1 year after performing the SQ and the SPICT (2016–17, n = 36)
| Selection by surprise | Selection SPICT by GPIS | Selection SPICT by GP | Age | Disease according to GPIS | Cause of death | Time between SQ/SPICT and death (days) | Practice | |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| 1 | Yes | Yes | Yes | 60–69 | Cancer | Larynx carcinoma | 238 | A |
| 2 | Yes | Yes | Yes | 60–69 | Cancer, COPD | Lung carcinoma | 199 | A |
| 3 | Yes | Yes | Yes | 70–79 | Cancer | Ovarian carcinoma | 263 | A |
| 4 | Yes | Yes | Yes | >80 | Cancer, dementia, heart failure | Colon carcinoma | 158 | B |
| 5 | Yes | Yes | Yes | >80 | Cancer, CVA | General deterioration | 327 | A |
| 6 | Yes | Yes | Yes | >80 | Cancer, heart failure, CVA | General deterioration | 323 | A |
| 7 | Yes | Yes | Yes | >80 | Cancer, heart and renal failure, CVA | General deterioration | 204 | A |
| 8 | Yes | Yes | Yes | >80 | Dementia, renal failure | General deterioration | 180 | A |
| 9 | Yes | Yes | Yes | >80 | COPD, renal failure, CVA | General deterioration | 124 | A |
| 10 | Yes | Yes | Yes | >80 | Cancer, dementia, neurological disease | General deterioration | 119 | A |
| 11 | Yes | Yes | Yes | >80 | Renal failure | General deterioration | 30 | A |
| 12 | Yes | Yes | Yes | >80 | COPD, renal failure, neurological disease | General deterioration, coma | 87 | A |
| 13 | Yes | Yes | Yes | >80 | Neurological disease | Old age | 99 | B |
| 14 | Yes | Yes | Yes | >80 | General deterioration | Sepsis | 61 | A |
| 15 | Yes | Yes | Yes | >80 | Heart failure, COPD, renal failure | Respiratory failure with heart/lung disease | 338 | A |
| 16 | Yes | Yes | Yes | >80 | Cancer, heart and renal failure | Heart failure | 134 | A |
| 17 | Yes | Yes | Yes | >80 | Cancer, heart and renal failure | Subdural haematoma after a fall | 220 | A |
|
| ||||||||
| 18 | No | Yes | Yes | 60–69 | Heart failure | Lung failure | 99 | B |
| 19 | No | Yes | Yes | 70–79 | CVA | Sudden death, possibly myocardial infarction | 344 | A |
| 20 | No | Yes | Yes | >80 | Cancer, COPD | Stomach carcinoma | 242 | A |
| 21 | No | Yes | Yes | >80 | Renal failure | Lung fibrosis | 196 | A |
|
| ||||||||
| 22 | Yes | Yes | No | 70–79 | Cancer | Mantle cell lymphoma | 37 | B |
|
| ||||||||
| 23 | No | Yes | No | <60 | CVA | Sudden death | 219 | B |
| 24 | No | Yes | No | >80 | CVA | Lung cancer, died within 2 weeks after diagnosis | 127 | B |
| 25 | No | Yes | No | >80 | Renal failure, CVA | CVA | 126 | A |
| 26 | No | Yes | No | >80 | Cancer (basal cell carcinoma), CVA | Endocarditis and multiple CVAs | 311 | B |
| 27 | No | Yes | No | >80 | Cancer (lung) | Dyspnoea with lung carcinoma | 232 | A |
| 28 | No | Yes | No | >80 | Cancer (non-Hodgkin, basal cell carcinoma) | Non-Hodgkin lymphoma | 280 | B |
| 29 | No | Yes | No | >80 | Cancer (breast, squamous cell carcinoma) | Cardiac arrest | 37 | B |
| 30 | No | Yes | No | >80 | Heart failure, renal failure | Cardiac asthma, found death | 276 | A |
|
| ||||||||
| 31 | No | No | No | 60–69 | Not in selection GPIS | Euthanasia with colon carcinoma | 319 | A |
| 32 | No | No | No | 60–69 | Not in selection GPIS | Fever and diarrhoea with abdominal focus | 272 | A |
| 33 | No | No | No | 60–69 | Not in selection GPIS | Ovarian carcinoma | 78 | A |
| 34 | No | No | No | 60–69 | Not in selection GPIS | Myocardial infarction | 14 | A |
| 35 | No | No | No | 70–79 | Not in selection GPIS | Oesophageal carcinoma | 316 | A |
| 36 | No | No | No | >80 | Not in selection GPIS | Metabolic acidosis with acute renal failure | 72 | A |
Performance characteristics of both tools of predicting 1-year mortality (both practices combined, n = 3640, 36 deceased in the year after performance of the tools, 2016–17)
| SQ ( | SPICT ( | |
|---|---|---|
| Sensitivity | 50% (34–66) | 58% (43–73) |
| Specificity | 99% (98–100) | 98% (97–98) |
|
| ||
| Sensitivity | 69% (50–84) | 81% (63–92) |
| Specificity | 99% (98–100) | 98% (97–98) |
Percentages (95% confidence interval).
aThe 10 patients that deceased relatively suddenly were included in the category ‘true negatives’ for the calculation of these performance characteristics.